Search For "drugs controller"
DCGI seeks clarification from Glenmark on its anti-viral favipiravir for u
Updated : 5 years, 8 months ago IST
New Delhi [India], July 19 (ANI): The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
Read More
Pharma giant Zydus Cadila initiates clinical study on 1,048 volunteers for
Updated : 5 years, 8 months ago IST
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
Read More
Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
Read More
DCGI instructs pharma giants manufacturing remdesivir to upload details of
Updated : 5 years, 8 months ago IST
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug
Read More
Sun Pharma initiates phase two clinical trial on AQCH as potential treatme
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
Read More
Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.
Read More
ICMR receives 99 applications to study efficacy of convalescent plasma to
Updated : 5 years, 11 months ago IST
New Delhi [India], April 20 (ANI): The Indian Council of Medical Research (ICMR) has received 99 applications for participation in "Randomized controlled study to assess the safety and efficacy of convalescent plasma to limit COVID-19 associated complications".
Read More
Lockdown effect: Top drug regulator instructs release of blocked consignme
Updated : 5 years, 11 months ago IST
New Delhi [India], April 3 (ANI): In the wake of coronavirus lockdown, the Central Drugs Controller has instructed all port offices of Central Drugs Standard Control Organization (CDCSO) to release the consignments of vaccines and critical in vitro diagnostics (IVDs) in public interest.
Read More
Punjab Health Minister hands over appointment letters to 11 drugs controll
Updated : 6 years, 2 months ago IST
Chandigarh (Punjab) [India], Jan 1 (ANI): To further improve the functioning of Punjab's Food and Drug Administration Department (FDA), Health Minster Balbir Singh Sidhu on Wednesday handed over the appointment letters to 11 drugs controller officers.
Read More